A mutation of human cytochrome c enhances the intrinsic apoptotic pathway but causes only thrombocytopenia

Nat Genet. 2008 Apr;40(4):387-9. doi: 10.1038/ng.103. Epub 2008 Mar 16.

Abstract

We report the first identified mutation in the gene encoding human cytochrome c (CYCS). Glycine 41, invariant throughout eukaryotes, is substituted by serine in a family with autosomal dominant thrombocytopenia caused by dysregulated platelet formation. The mutation yields a cytochrome c variant with enhanced apoptotic activity in vitro. Notably, the family has no other phenotypic indication of abnormal apoptosis, implying that cytochrome c activity is not a critical regulator of most physiological apoptosis.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Apoptosis / physiology*
  • Apoptotic Protease-Activating Factor 1 / metabolism
  • Cytochromes c / genetics*
  • Female
  • Genetic Linkage
  • Humans
  • Male
  • Megakaryocytes / metabolism
  • Megakaryocytes / pathology
  • Mutation / genetics*
  • Oxidation-Reduction
  • Pedigree
  • Platelet Count
  • Serine / chemistry
  • Serine / genetics
  • Signal Transduction*
  • Thrombocytopenia / etiology*
  • Thrombocytopenia / pathology

Substances

  • APAF1 protein, human
  • Apoptotic Protease-Activating Factor 1
  • Serine
  • Cytochromes c